Inhibitors of Dipeptidyl Peptidase I (DPPI) As Mast Cell Stabilising Agents/ ghada mohamed abd elhaleem elfeki ; mohamed a. badawy , mohamed a. el-desouky , andrew f. walls.
Material type: TextPublication details: 2022.Content type:- text
- Unmediated
- volume
- مثبطات لإنزيم تحلل ثنائى الرابطة البيبتيدية الاول DPPI كعوامل استقرار لخلايا الصبغة القاعدية
- 540
Item type | Current library | Home library | Call number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.12.02.ph.D.2022.Gh.I (Browse shelf(Opens below)) | Not for loan | 01010110086141000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (Ph.D)-Cairo University,2022.
Bibliography: p. 94-104.
Inhibitors of mast cell tryptase and chymase are potent inhibitors of mast cell activation. These abundant mast cell proteases may be converted into catalytically active forms by dipeptidyl peptidase 1 (DPPI), but the potential role of DPPI in degranulation is not known. Cells of the LAD2 human mast cell line and RBL rat mast cell line were sensitized with myeloma IgE and activated with anti-IgE antibody or calcium ionophore A23817. Concentrations of β-hexosaminidase were determined in supernatants and cell lysates, and also tryptase and DPPI using specific ELISA or chromogenic substrates. Cells were pre-incubated with the DPPI inhibitor Gly-Phe-CHN2 (GFCN) or with the small molecule of DPPI inhibitors PZ610, PZ709 or PZ889 for 0, 5 or 30 minutes Parallel studies were conducted with mast cells dispersed from human tonsil, in which histamine release was also determined.
There are no comments on this title.